Ac-225-PSMA-62

Actinium-225 labeled PSMA-62 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ac-225-PSMA-62, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer [Phase 1]

See pricing